Patent Assignment
Reel/Frame 019667/0745
Corrective Assignment to Correct the Serial Number Was Incorrect. Changing Serial No. from: 60/873,706 to: 60/873,760 Previously Recorded on Reel 019065 Frame 0067. Assignor(S) Hereby Confirms the Assignment from Inventor Daniel C. Adelman to Sunesis Pharmaceuticals Filed on 12/08/2006..
Recorded: 2007-08-08
Pages: 4
Assignor
ADELMAN, DANIEL C.
Executed: 2007-07-25
Assignee
SUNESIS PHARMACEUTICALS, INC.
555 TECHNOLOGY COURT, SUITE 150, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphtyridine-3-carboxylic acid for treatment of hematologic malignancies
Application:
60/873,760 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
May 7, 2012
From: SUNESIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 028169/0528 →
Security Interest
May 10, 2016
From: SUNESIS PHARMACEUTICALS, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 038655/0493 →
Release of Security Interest
Nov 5, 2020
From: WESTERN ALLIANCE BANK
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 054335/0429 →